Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
General and administrative: 482.12K
Today's EPS Names:
KG, NHC, NATH, More
Financial Fact:
General and administrative: 482.12K
Today's EPS Names:
KG, NHC, NATH, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q3 EPS of ($0.10), $0.60 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $5.23 million versus the consensus estimate of $136.4 million.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Starz Entertainment Corp. (STRZ) Reports Q2 Loss of $11.27
- Gyre Therapeutics (GYRE) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
